Cargando…

ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?

Detalles Bibliográficos
Autores principales:	Bazarbachi, Ali, Suarez, Felipe, Marcais, Ambroise, Hermine, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043418/ http://dx.doi.org/10.1186/1742-4690-11-S1-O30

Ejemplares similares

Arsenic trioxyde in the treatment of HTLV1 associated ATLL
por: Suarez, Felipe, et al.
Publicado: (2011)

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment
por: Marçais, Ambroise, et al.
Publicado: (2012)

HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia/Lymphoma (ATLL) development
por: Banerjee, Prabal, et al.
Publicado: (2009)

Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
por: Tsukasaki, Kunihiro, et al.
Publicado: (2020)

Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)

Recurrent TET2 mutations in adult T cell leukemia (ATL) and identification of a Single Nucleotide polymorphism in TET2 region predisposing to ATL development
por: Marçais, Ambroise, et al.
Publicado: (2015)

Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2011)

Neurolymphomatosis in patient with Adult T-cell leukaemia/lymphoma (ATLL)
por: Yoshimitsu, Maki, et al.
Publicado: (2015)

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” micro-environment in patients with adult T-cell leukemia lymphoma
por: Kchour, Ghada, et al.
Publicado: (2014)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma
por: Marçais, Ambroise, et al.
Publicado: (2020)

The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis
por: Oliveira, Pedro Dantas, et al.
Publicado: (2022)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

Novel Treatments of Adult T Cell Leukemia Lymphoma
por: El Hajj, Hiba, et al.
Publicado: (2020)

Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells
por: Nakahata, Shingo, et al.
Publicado: (2011)

S106: METABOLIC PLASTICITY REVEALS A TARGETABLE VULNERABILITY IN LEUKEMIA
por: Andrieu, Guillaume, et al.
Publicado: (2023)

Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
por: Sibon, David, et al.
Publicado: (2015)

Cumulative kinetics of epigenetic abnormalities during initiation and progression of Adult T-cell Leukemia/Lymphoma (ATLL)
por: Oka, Takashi, et al.
Publicado: (2011)

Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)
por: Xu, Xin, et al.
Publicado: (2020)

Treatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon
por: Turpin, Jocelyn, et al.
Publicado: (2015)

Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
por: Marino-Merlo, Francesca, et al.
Publicado: (2018)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Clinical features and outcome of adult T-cell leukemia/lymphoma: University of Miami experience
por: Pimentel, Agustin, et al.
Publicado: (2014)

Guillain-Barré-like Syndrome, as a Rare Presentation of Adult T-cell Leukemia-Lymphoma (ATLL): A Case Report
por: Sasannejad, Payam, et al.
Publicado: (2012)

Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells
por: El Hajj, Hiba, et al.
Publicado: (2021)

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression
por: Marçais, Ambroise, et al.
Publicado: (2016)

Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
por: Cho, Ilseung, et al.
Publicado: (2015)

Controversies in Targeted Therapy of Adult T Cell Leukemia/Lymphoma: ON Target or OFF Target Effects?
por: Nasr, Rihab, et al.
Publicado: (2011)

Baseline CD8 T-cell activation is not associated with survival in ATLL
por: Taylor, Graham P, et al.
Publicado: (2015)

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
por: Cook, Lucy B., et al.
Publicado: (2019)

Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis
por: Shafiee, Arman, et al.
Publicado: (2023)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Rehabilitation in adult scoliosis: introduction
por: Negrini, Stefano
Publicado: (2010)

S274: A NEW, EFFECTIVE, SAFE, NON-MYELOABLATIVE CONDITIONING REGIMEN WITH A HLA-MATCHED SIBLING DONOR FOR THE SEVERE SICKLE CELL PHENOTYPE IN ADULTS
por: Ihlem, Rahal, et al.
Publicado: (2023)

A phase II study of lenalidomide in patients with relapsed or refractory ATLL
por: Phillips, Adrienne A, et al.
Publicado: (2014)

Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival
por: Hleihel, Rita, et al.
Publicado: (2023)

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia
por: Forlani, Greta, et al.
Publicado: (2021)

130 Reinhard Kurth Honorary Lecture HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation
por: Hall, William W, et al.
Publicado: (2014)

Deciphering the molecular basis of arsenic/interferon-alpha induced eradication of leukemia initiating cells in adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dnednr98osl5nje41d7pttdqv4